SE415763B - Forfarande for framstellning av 1,3-ditiolanyl(2)-och 1,3-ditianyl(2)-foreningar med koronardilaterande egenskaper - Google Patents

Forfarande for framstellning av 1,3-ditiolanyl(2)-och 1,3-ditianyl(2)-foreningar med koronardilaterande egenskaper

Info

Publication number
SE415763B
SE415763B SE7416086A SE7416086A SE415763B SE 415763 B SE415763 B SE 415763B SE 7416086 A SE7416086 A SE 7416086A SE 7416086 A SE7416086 A SE 7416086A SE 415763 B SE415763 B SE 415763B
Authority
SE
Sweden
Prior art keywords
ditiolanyl
coronardilating
ditianyl
substances
procedure
Prior art date
Application number
SE7416086A
Other languages
English (en)
Swedish (sv)
Other versions
SE7416086L (de
Inventor
H Ramuz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE7416086L publication Critical patent/SE7416086L/xx
Publication of SE415763B publication Critical patent/SE415763B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SE7416086A 1973-12-21 1974-12-19 Forfarande for framstellning av 1,3-ditiolanyl(2)-och 1,3-ditianyl(2)-foreningar med koronardilaterande egenskaper SE415763B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1803073A CH611614A5 (en) 1973-12-21 1973-12-21 Process for the preparation of heterocyclic compounds

Publications (2)

Publication Number Publication Date
SE7416086L SE7416086L (de) 1975-06-23
SE415763B true SE415763B (sv) 1980-10-27

Family

ID=4429892

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7416086A SE415763B (sv) 1973-12-21 1974-12-19 Forfarande for framstellning av 1,3-ditiolanyl(2)-och 1,3-ditianyl(2)-foreningar med koronardilaterande egenskaper
SE7804879A SE434746B (sv) 1973-12-21 1978-04-27 2-fenyl-m-ditianderivat till anvendning som mellanprodukter vid syntes av m-ditianderivat med koronardilaterande egenskaper

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7804879A SE434746B (sv) 1973-12-21 1978-04-27 2-fenyl-m-ditianderivat till anvendning som mellanprodukter vid syntes av m-ditianderivat med koronardilaterande egenskaper

Country Status (24)

Country Link
JP (1) JPS595594B2 (de)
AT (5) AT344693B (de)
AU (1) AU511714B2 (de)
BE (1) BE823625A (de)
CA (4) CA1057295A (de)
CH (3) CH611614A5 (de)
DD (1) DD116829A5 (de)
DE (2) DE2463173C2 (de)
DK (1) DK148323C (de)
ES (5) ES433172A1 (de)
FI (2) FI67216C (de)
FR (1) FR2255064B1 (de)
GB (3) GB1489088A (de)
HK (1) HK43380A (de)
HU (1) HU170429B (de)
IE (1) IE40788B1 (de)
IL (3) IL46146A (de)
LU (1) LU71530A1 (de)
NL (1) NL158496B (de)
NO (1) NO142669C (de)
PH (3) PH19393A (de)
SE (2) SE415763B (de)
YU (1) YU39311B (de)
ZA (1) ZA747526B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515173A1 (fr) * 1981-10-28 1983-04-29 Delalande Sa Nouveaux derives du benzaldehyde 3-4-diethere et leur procede de preparation
JPS60142297U (ja) * 1984-02-29 1985-09-20 株式会社豊田自動織機製作所 フオ−クリフトにおける旋回型運転席の回転装置
JPS62171328U (de) * 1986-04-23 1987-10-30
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
US5434179A (en) * 1989-06-06 1995-07-18 Takeda Chemical Industries, Ltd. Method for improving brain function using cholinesterase-inhibiting aminoketone compounds
JP3878178B2 (ja) 2001-12-28 2007-02-07 武田薬品工業株式会社 排尿障害予防治療剤
WO2010006103A1 (en) * 2008-07-10 2010-01-14 Ore Pharmaceuticals Inc. Method for enhancing cognition or inhibiting cognitive decline

Also Published As

Publication number Publication date
CH620920A5 (en) 1980-12-31
AT350053B (de) 1979-05-10
ES451134A1 (es) 1977-08-16
AT349012B (de) 1979-03-12
CA1072966A (en) 1980-03-04
DE2460593B2 (de) 1979-01-18
DE2463173C2 (de) 1987-01-29
CH620921A5 (en) 1980-12-31
NO142669C (no) 1980-09-24
NO744615L (de) 1975-07-21
BE823625A (fr) 1975-06-20
ATA38978A (de) 1978-10-15
CA1086320A (en) 1980-09-23
DD116829A5 (de) 1975-12-12
YU336874A (en) 1982-05-31
AT349013B (de) 1979-03-12
DK148323B (da) 1985-06-10
HK43380A (en) 1980-08-22
PH13326A (en) 1980-03-13
FI801053A7 (fi) 1981-01-01
FR2255064A1 (de) 1975-07-18
ZA747526B (en) 1975-12-31
ATA39178A (de) 1978-08-15
AT349014B (de) 1979-03-12
IL46146A0 (en) 1975-03-13
HU170429B (de) 1977-06-28
NO142669B (no) 1980-06-16
ES451135A1 (es) 1977-08-16
IE40788B1 (en) 1979-08-15
SE7416086L (de) 1975-06-23
FI67216B (fi) 1984-10-31
DE2460593A1 (de) 1975-07-03
CA1079290A (en) 1980-06-10
DK668174A (de) 1975-08-25
ATA38778A (de) 1978-08-15
SE434746B (sv) 1984-08-13
FR2255064B1 (de) 1978-03-24
GB1489087A (en) 1977-10-19
JPS5095267A (de) 1975-07-29
CH611614A5 (en) 1979-06-15
ATA38878A (de) 1978-08-15
PH13396A (en) 1980-03-28
IE40788L (en) 1975-06-21
IL52844A0 (en) 1977-10-31
AU7600874A (en) 1976-06-03
AT344693B (de) 1978-08-10
YU39311B (en) 1984-10-31
FI352774A7 (de) 1975-06-22
GB1489086A (en) 1977-10-19
ES433172A1 (es) 1977-04-16
DE2460593C3 (de) 1979-09-13
ATA1022674A (de) 1977-12-15
ES451136A1 (es) 1977-10-01
CA1057295A (en) 1979-06-26
AU511714B2 (en) 1980-09-04
IL46146A (en) 1980-09-16
NL7416507A (nl) 1975-06-24
PH19393A (en) 1986-04-07
JPS595594B2 (ja) 1984-02-06
GB1489088A (en) 1977-10-19
LU71530A1 (de) 1976-11-11
AU3224278A (en) 1978-05-25
FI67216C (fi) 1985-02-11
ES451137A1 (es) 1977-08-16
IL52843A0 (en) 1977-10-31
NL158496B (nl) 1978-11-15
DK148323C (da) 1986-03-03

Similar Documents

Publication Publication Date Title
SE7710600L (sv) Forfarande for framstellning av 1,3-bensoxazoler
IL46926A0 (en) The preparation of 2-arylamino-2-imidazoline derivatives and certain novel 2-dihaloarylamino-2-imidazoline derivatives
SE409459B (sv) Forfarande for framstellning av 6'-deoxi-6'-substituerat eller-osubstituerat amino-lividomycin
AR204390A1 (es) Procedimiento de preparacion de derivados de imidazolidinonas y perhidropirimidinonas n,n' bisustituidas
SE407937B (sv) Forfarande for framstellning av 1,3,4-substituerade 2-pyrrolidoner med terapentiska egenskaper
SE7505736L (sv) Polylaurinlactam, forfarande for framstellning av hogre polylactamer och deras anvendning
SE405736B (sv) Forfarande for framstellning av polymerblandningar med klibbformaga
SE431451B (sv) Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
SE426242B (sv) Analogiforfarande for framstellning av 1,4-bensodiazepinderivat
GB1404457A (en) Preparation of 2,6-dinitoaniline derivatives
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE415659B (sv) Forfarande for framstellning av basiskt substituerade xanten- och tioxantenderivat
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
TR18100A (tr) 2,4-dienoksi-6 (alkoksililalkilamino)-striazinlerin imaline mahsus usul ve bunlarin kullanilmasi
CA1036164A (en) Derivatives of 2-amino-indane, the preparation and use thereof
ZA747672B (en) New derivatives of 1,3-benzodioxole and the preparation thereof
CA997786A (en) Derivatives of 2-amino-indane, the preparation and use thereof
CA997765A (en) Derivatives of 2-amino-indane, the preparation and use thereof
NO140981C (no) Fremgangsmaate ved fremstilling av 4-alfa-hydroxy-2,9-dioxatricyclo(4,3,1,0 3,7)-decan og estere derav
TR17624A (tr) 1-alkilidenaminourasiller,bunlarin hazirlanmasina mahsus usul ve bunlarin herbisid olarak kullanilmasi
SE7808849L (sv) Forfarande for framstellning av 9,11,15-trihydroxi-13,14-dehydroprostaglandiner och prost-5-en-13-ynsyraderivat
ZA745608B (en) 3,3-methylene-bis-(4-hydroxy-5-azacoumarin) its preparation and use
ZA726310B (en) New nitrofuran derivatives and the preparation thereof
TR18293A (tr) Asillenmis uereler hazirlanmalarina mahsus usul ve herbisid olarak kullanilmarari
NO138146C (no) Fremgangsmaate for fremstilling av 2,2`-anhydro-1beta-d-arabinfuranosyl-5-cytosin

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7416086-2

Effective date: 19910704

Format of ref document f/p: F